MedPath

Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy

Not Applicable
Completed
Conditions
Anxiety Disorder
Fatigue
Pain
Malignant Neoplasm
Nausea and Vomiting
Interventions
Other: questionnaire administration
Procedure: therapeutic touch
Behavioral: management of therapy complications
Procedure: standard follow-up care
Registration Number
NCT01553578
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

This randomized clinical trial studies healing touch or guided imagery in treating pain, fatigue, nausea, and anxiety in patients undergoing chemotherapy. Healing touch and guided imagery may help treat complications caused by chemotherapy. It is not yet known whether healing touch or guided imagery is more effective in treating pain, fatigue, nausea, and anxiety in patients undergoing chemotherapy

Detailed Description

PRIMARY OBJECTIVES:

I. To determine if the provision of healing touch or guided imagery during outpatient chemotherapy is associated with decreased pain, fatigue, nausea and anxiety when compared to standard outpatient treatment protocols.

OUTLINE: Patients are randomized to 1 of 3 treatment arms.

ARM A: Patients receive 30 minutes of healing touch therapy comprising magnetic clearing, pain drains, hands in motion/hands still and mind clearing.

ARM B: Patients listen to guided imagery audiotapes for 30 minutes

ARM C: Patients receive standard of care.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
244
Inclusion Criteria
  • Adult patients at the outpatient chemotherapy area will be enrolled without consideration for type of cancer or chemotherapeutic agents to be used
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm A (healing touch therapy)questionnaire administrationPatients receive 30 minutes of healing touch therapy consisting of magnetic clearing, pain drains, hands in motion/hands still and mind clearing.
Arm A (healing touch therapy)therapeutic touchPatients receive 30 minutes of healing touch therapy consisting of magnetic clearing, pain drains, hands in motion/hands still and mind clearing.
Arm C (standard care)questionnaire administrationPatients receive standard of care.
Arm B (guided imagery)management of therapy complicationsPatients listen to guided imagery audiotapes for 30 minutes.
Arm A (healing touch therapy)management of therapy complicationsPatients receive 30 minutes of healing touch therapy consisting of magnetic clearing, pain drains, hands in motion/hands still and mind clearing.
Arm B (guided imagery)questionnaire administrationPatients listen to guided imagery audiotapes for 30 minutes.
Arm C (standard care)standard follow-up carePatients receive standard of care.
Primary Outcome Measures
NameTimeMethod
Change scores for each patient on fatigue scaleApproximately 6 months

Collected using a 10 point visual analog scale for pain, fatigue, nausea, and anxiety. Analyzed initially using descriptive statistics. Compared among the 3 groups using one-way analysis of variance (ANOVA) models and 2-sample t-tests.

Change scores for each patient on anxiety scaleApproximately 6 months

Collected using a 10 point visual analog scale for pain, fatigue, nausea, and anxiety. Analyzed initially using descriptive statistics. Compared among the 3 groups using one-way analysis of variance (ANOVA) models and 2-sample t-tests.

Change scores for each patient on pain scaleApproximately 6 months

Collected using a 10 point visual analog scale for pain, fatigue, nausea, and anxiety. Analyzed initially using descriptive statistics. Compared among the 3 groups using one-way analysis of variance (ANOVA) models and 2-sample t-tests.

Change scores for each patient on nausea scaleApproximately 6 months

Collected using a 10 point visual analog scale for pain, fatigue, nausea, and anxiety. Analyzed initially using descriptive statistics. Compared among the 3 groups using one-way analysis of variance (ANOVA) models and 2-sample t-tests.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Comprehensive Cancer Center of Wake Forest University

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath